Effective Reduction of SARS-CoV-2 RNA Levels Using a Tailor-Made Oligonucleotide-Based RNA Inhibitor

In only two years, the coronavirus disease 2019 (COVID-19) pandemic has had a devastating effect on public health all over the world and caused irreparable economic damage across all countries. Due to the limited therapeutic management of COVID-19 and the lack of tailor-made antiviral agents, findin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Veronika Nemethova, Petra Mazancova, Michal Selc, Kristina Jakic, Lucia Uhelska, Boglarka Nemethova, Alexandra Poturnayova, Lubos Drgona, Andrea Babelova, Filip Razga
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-03-01
Colecção:Viruses
Assuntos:
SARS-CoV-2
COVID-19
RNA levels
oligonucleotide-based RNA inhibitor
RdRp
Acesso em linha:https://www.mdpi.com/1999-4915/14/4/685
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados